Share
The BMJ brings you interviews with the people who are shaping medicine and science around the world.
…
continue reading
Manage episode 519077627 series 2464201
Content provided by Psychopharmacology Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychopharmacology Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode, we challenge conventional prescribing by exploring why lithium should be the first-line treatment for acute classic mania, despite widespread use of antipsychotics. Dr. David Osser presents evidence-based arguments for lithium's unique neuroprotective benefits and long-term efficacy.
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.
109 episodes
))
